11/4
08:19 am
avxl
Anavex Life Sciences Corp. (NASDAQ: AVXL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Medium
Report
Anavex Life Sciences Corp. (NASDAQ: AVXL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
10/31
04:07 am
avxl
Anavex's Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer's Trial: Data Presented at CTAD Conference 2024 [Yahoo! Finance]
High
Report
Anavex's Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer's Trial: Data Presented at CTAD Conference 2024 [Yahoo! Finance]
10/31
04:00 am
avxl
Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
High
Report
Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
10/18
08:33 am
avxl
Anavex Life Sciences Corp. (NASDAQ: AVXL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
Anavex Life Sciences Corp. (NASDAQ: AVXL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
10/17
07:30 am
avxl
Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
Low
Report
Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
9/20
09:04 am
avxl
Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near? [Yahoo! Finance]
Low
Report
Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near? [Yahoo! Finance]
9/3
07:30 am
avxl
Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024
Medium
Report
Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024